One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Blood Glucose Monitoring System Market

Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022


Product Code : MNMHC00109153
Survey : MarketsandMarkets
Publish On : 20, May, 2022
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The blood glucose monitoring system market projected to grow at a CAGR of 4.8%.”
The global blood glucose monitoring system market is projected to reach USD 10.58 billion by 2022 from an estimated USD 8.35 billion in 2017, at a CAGR of 4.8% during the forecast period. The key factors driving the growth of this market include rising prevalence of diabetic population, and increasing product launches. However, the high cost and poor reimbursements is expected to restrain the growth of this market during the forecast period.

By patient care setting, the self/home care segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
Based on patient care setting, the market is segmented into self/home care and hospitals/clinics. The self/home care segment is expected to account for the largest share of the blood glucose monitoring system market. This can be attributed to high adoption of these devices for home use owing to technological advancements increasing their accuracy and patient comfort.

“By application, the type 1 diabetes segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
Based on application, the market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes.
The type 1 diabetes segment is expected to grow at a highest CAGR owing to increasing product launches of continuous glucose monitors that are used for better management of type 1 diabetes.

“North America to witness the highest growth during the forecast period (2017-2022)”
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs and rising FDA approvals in the US.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–50%, Tier 2–30% and Tier 3–20%
• By Designation – C-level–30%, Director Level–48%, Others–22%
• By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%

The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).`
Research Coverage:
The report analyzes the blood glucose monitoring system market and aims at estimating the market size and future growth potential of this market based on various segments such as product, testing site, patient care setting, application, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the blood glucose monitoring system market. The report analyzes the market based on product, testing site, patient care setting, application
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the blood glucose monitoring system market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various blood glucose monitoring system across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the blood glucose monitoring system market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the blood glucose monitoring system market

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DESIGN 20
2.2 RESEARCH APPROACH 21
2.2.1 SECONDARY RESEARCH 22
2.2.2 PRIMARY RESEARCH 23
2.3 MARKET SIZE ESTIMATION 26
2.4 MARKET DATA VALIDATION AND TRIANGULATION 28
2.5 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS: MARKET OVERVIEW 35
4.2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT 35
4.3 GEOGRAPHIC ANALYSIS: GLOBAL SELF-MONITORING/ TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT 36
4.4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT 37
4.5 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING 37
4.6 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION 38
4.7 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE 38
4.8 GEOGRAPHIC SNAPSHOT: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Growing prevalence of diabetes 41
5.2.1.2 Increasing number of product launches 42

5.2.2 RESTRAINT 43
5.2.2.1 High cost and poor reimbursement of blood glucose monitoring systems and supplies 43
5.2.3 OPPORTUNITY 43
5.2.3.1 Pipeline products and ongoing research 43
5.2.4 CHALLENGE 44
5.2.4.1 Invasiveness of blood glucose monitors 44
6 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT 45
6.1 INTRODUCTION 46
6.2 SELF-MONITORING BLOOD GLUCOSE SYSTEMS 47
6.2.1 BLOOD GLUCOSE METERS 48
6.2.2 TESTING STRIPS 49
6.2.3 LANCETS & LANCING DEVICES 50
6.3 CONTINUOUS GLUCOSE MONITORING SYSTEMS 53
6.3.1 SENSORS 54
6.3.2 TRANSMITTERS 55
6.3.3 RECEIVERS 56
7 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE 57
7.1 INTRODUCTION 58
7.2 FINGERTIP TESTING 59
7.3 ALTERNATE SITE TESTING 60
8 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING 61
8.1 INTRODUCTION 62
8.2 SELF/HOME CARE 63
8.3 HOSPITALS & CLINICS 64
9 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION 65
9.1 INTRODUCTION 66
9.2 DIABETES 67
9.2.1 TYPE 2 DIABETES 67
9.2.1.1 Adults 68
9.2.1.2 Pediatrics 69
9.2.2 TYPE 1 DIABETES 69
9.2.2.1 Adults 70
9.2.2.2 Pediatrics 71
9.2.3 GESTATIONAL DIABETES 72

10 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION 73
10.1 INTRODUCTION 74
10.2 NORTH AMERICA 75
10.2.1 US 79
10.2.2 CANADA 84
10.3 EUROPE 88
10.3.1 GERMANY 92
10.3.2 UK 96
10.3.3 FRANCE 99
10.3.4 REST OF EUROPE (ROE) 102
10.4 ASIA PACIFIC (APAC) 106
10.4.1 CHINA 110
10.4.2 INDIA 113
10.4.3 JAPAN 116
10.4.4 REST OF APAC 119
10.5 REST OF THE WORLD (ROW) 124
11 COMPETITIVE LANDSCAPE 130
11.1 OVERVIEW 130
11.2 MARKET SHARE ANALYSIS 130
11.2.1 SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET 130
11.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET 132
11.3 COMPETITIVE SCENARIO 134
11.3.1 PRODUCT LAUNCHES AND APPROVALS 135
11.3.2 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS 135
11.3.3 EXPANSIONS 136
11.3.4 ACQUISITIONS 137
12 COMPANY PROFILES 138
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 ABBOTT LABORATORIES 138
12.2 F. HOFFMANN-LA ROCHE 141
12.3 LIFESCAN 144
12.4 ASCENSIA DIABETES CARE 146
12.5 DEXCOM 148
12.6 MEDTRONIC 152
12.7 YPSOMED 155
12.8 B. BRAUN MELSUNGEN 157
12.9 NIPRO 159
12.10 SANOFI 161
12.11 ARKRAY 163
12.12 PRODIGY DIABETES CARE 165
12.13 ACON LABORATORIES 166
12.14 NOVA BIOMEDICAL 168

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 170
13.1 DISCUSSION GUIDE 170
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 176
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 178
13.4 AVAILABLE CUSTOMIZATIONS 179
13.5 RELATED REPORTS 180
13.6 AUTHOR DETAILS 181

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+